Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

moderna_norwood_plant

EU approves Moderna’s COVID-19 vaccine

January 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine

The European Commission has granted a Condition Marketing Authorisation (CMA) for Moderna’s COVID-19 vaccine, meaning the jab will soon be …
News
herbert

Clinigen appoints Sam Herbert as Chief Operating Officer

January 5, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinigen, the global pharmaceutical and services company, has appointed Sam Herbert as Chief Operating Officer with immediate effect.
Appointment
screenshot_2021-01-05_puretech_announces_the_appointment_of_george_farmer_ph_d__as_chief_financial_officer_biospace

PureTech appoints George Farmer as Chief Financial Officer

January 5, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PureTech Health, a clinical-stage biotherapeutics company focused on highly differentiated medicines for devastating diseases, has appointed Dr George Farmer as …
Appointment
pfizer_building_logo1

EU states to receive 100m extra doses of Pfizer-BioNTech vaccine

January 4, 2021 Sales and Marketing COVID-19, EU, Pfizer, Vaccine

Pfizer and BioNTech have announced they will supply an additional 100 million doses of their COVID-19 vaccine, COMIRNATY, to the …
News
vaccination

Concern as India approves COVID-19 vaccine before trial completion

January 4, 2021 Sales and Marketing COVID-19, Vaccine

Experts have expressed concern over India’s emergency approval of its homegrown COVID-19 vaccine, Covaxin, before studies have been completed. The …
News
static

Moderna’s COVID-19 vaccine achieves over 90% efficacy in Phase III trial

January 4, 2021 Sales and Marketing COVID-19, Moderna

Moderna’s COVID-19 vaccine has achieved over 90% efficacy in interim safety and primary efficacy results following its Phase III trial. …
News
opaganib-bottle-and-tablets

RedHill announces positive top-line data for COVID-19 pneumonia drug

January 4, 2021 Sales and Marketing COVID-19

RedHill Biopharma has announced that preliminary top-line data from its US Phase II study with orally-administered opaganib (Yeliva) in patients …
News
astrazeneca-sign

UK becomes first country to roll out Oxford University-AstraZeneca COVID-19 vaccine

January 4, 2021 Sales and Marketing AstraZeneca, COVID-19, Vaccine

The UK has become the first country to administer the Oxford University-AstraZeneca COVID-19 vaccine to its population as coronavirus case …
News
1517679969844

Novavax appoints Rick Crowley as Executive Vice President, Chief Operations Officer.

December 22, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novavax, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, has announced the appointment of Rick Crowley to …
Appointment

The importance of ethics and patient centricity in managed and early access programmes

December 21, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Matt Fellows explores how early and managed access schemes are mutually beneficial to sponsors and patients alike, as well as how …
Feature
1516998199715

4BIO Capital appoints Akiko Iwasaki to its Scientific Advisory Board

December 21, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

4BIO Capital, an international venture capital firm focused on advanced therapies addressing high unmet medical and social needs, has appointed …
Appointment

Shionogi’s novel antibiotic selected for UK pilot subscription reimbursement model

December 21, 2020 Sales and Marketing NICE, Shionogi, antibiotic

Japanese pharmaceutical company Shionogi today announced that NICE and NHS England and Improvement (NHSE&I) have selected its novel antibiotic Fetcroja …
News
european_commission_web

European Commission approves EU’s first peanut allergy treatment

December 21, 2020 Sales and Marketing Aimmune, European Commission, allergy

Aimmune Therapeutics today announced that the European Commission (EC) has approved PALFORZIA as the EU’s first-ever treatment of peanut allergy. …
News
astrazeneca_plaque

AstraZeneca’s cancer drug Tagrisso gets FDA approval

December 21, 2020 Sales and Marketing AstraZeneca, Cancer, FDA

The FDA has approved AstraZeneca’s Tagrisso (osimertinib) for the adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated …
News
fda2outsideweb

Moderna’s COVID-19 vaccine receives emergency approval from FDA

December 21, 2020 Sales and Marketing COVID-19, FDA, Moderna, US, Vaccine

Moderna has announced that the FDA yesterday authorised the emergency use of mRNA-1273, the biotechnology company’s vaccine against COVID-19 in …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026